EFDID: 373515EFD: View Filing

Issuer: Ashvattha Therapeutics, Inc. (0001668528) - D/A

Accession: 0001104659-22-131412 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001668528
  • Entity Name:
    Ashvattha Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    CALIFORNIA
  • Year of Inc:
    Over 5 years ago
  • Address:
    1235 RADIO ROAD, SUITE 200
    REDWOOD CITY, CA 94065
  • Persons:
    Related Persons 4
    Jeffrey Cleland
    Executive Officer, Director
    Yuhang Zhao
    Director
    George Montgomery
    Director
    Jay Zaveri
    Director
EDGAR: Offering Information
  • Accession Date:
    12/30/2022
  • First Sale Date:
    04/16/2021
  • Offering Amount:
    Indefinite
  • Amount Sold:
    $60,181,969
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    The offering is ongoing.
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:AL, CA, CT, IN, MA, MI, NC, NJ, TX
Inactive:CO, IL, NY, VT
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
GP Numenkari Inc. 153480 None None AL, CA, CT, FL, GA, MA, MI, NJ, NY, NC, TX
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Ashvattha Therapeutics, Inc./s/ Jeffrey ClelandJeffrey ClelandPresident2022-12-29
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Dec. 30, 2022 373515: 0001104659-22-131412 Ashvattha Therapeutics, Inc.
Amount Sold: $60,181,969
D May. 03, 2021 373515: 0001104659-21-060161 Ashvattha Therapeutics, Inc.
Offer Amount: $9,564,619
Amount Sold: $7,725,000
Remaining: $1,839,619